Decreased prevalence of high-risk human papillomavirus infection is associated with obesity

European Journal of Gynaecological Oncology

Volumn 34, Issue 1, 2013, Pages 70-74

  Jung, U S ^a   Choi, J S ^b   Ko, J H ^b   Lee, J H ^c   Park, S Y ^c   Park, S H ^d  

^a Konyang University College of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Dr Park's Ob and Gyn Clinic   (South Korea)

Author keywords

HPV; Obesity; Prevalence; Risk factor

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MARRIAGE; OBESITY; PAPILLOMAVIRUS INFECTION; PERIODIC MEDICAL EXAMINATION; PREVALENCE; SMOKING; SOUTH KOREA;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; OBESITY; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875021342     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.
2. Sillman F.H., Sentovich S., Shaffer D.: "Ano-genital neoplasia in renal transplant patients". Ann. Transplant., 1997, 2, 59.
3. Ferenczy A., Coutlee F., Franco E., Hankins C.: "Human papillomavirus and HlV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments". C.M.A.J., 2003, 169, 431.
4. Shin H.R., Lee D.H., Herrero R., Smith J.S., Vaccarella S., Hong S.H., et al.: "Prevalence of human papillomavirus infection in women in Busan, South Korea". Int. J. Cancer, 2003, 103, 413.
5. Steben M., Duarte-Franco E.: "Human papillomavirus infection: epidemiology and pathophysiology". Gynecol. Oncol., 2007, 107, 5.
6. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D.: "Natural history of cervicovaginal papillomavirus infection in young women". N. Engl. J. Med., 1998, 338, 423.
7. Bosch F.X., de Sanjose S.: "The epidemiology of human papillomavirus infection and cervical cancer". Dis. Markers, 2007, 23, 213.
8. Kahn J.A., Lan D., Kahn R.S.: "Sociodemographic factors associated with high-risk human papillomavirus infection". Obstet. Gynecol., 2007, 110, 87.
9. Winer R.L., Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., Holmes K.K., et al.: "Condom use and the risk of genital human papillomavirus infection in young women". N. Engl. J. Med., 2006, 354, 2645.
10. Rieck G., Fiander A.: "The effect of lifestyle factors on gynaecological cancer". Best Pract. Res. Clin. Obstet. Gynaecol., 2006, 20, 227.
11. Wolk A., Gridley G., Svensson M., Nyren O., McLaughlin J.K., Fraumeni J.F., et al.: "A prospective study of obesity and cancer risk (Sweden)". Cancer Causes Control, 2001, 12, 13.
12. Moller H., Mellemgaard A., Lindvig K., Olsen J.H.: "Obesity and cancer risk: a Danish record-linkage study". Eur. J. Cancer, 1994, 30A, 344.
13. Lacey J.V. Jr., Swanson C.A., Brinton L.A., Altekruse S.F., Barnes W.A., Gravitt P.E., et al.: "Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix". Cancer, 2003, 95, 814.
14. Nyholm M., Gullberg B., Haglund B., Rastam L., Lindblad U.: "Higher education and more physical activity limit the development of obesity in a Swedish rural population. The Skaraborg Project". Int. J. Obes., (Lond) 2008, 32, 533.
15. Chang V.W., Lauderdale D.S.: "Income disparities in body mass index and obesity in the United States, 1971-2002". Arch. Intern. Med., 2005, 165, 2122.
16. Ferrante J.M., Chen P.H., Crabtree B.F., Wartenberg D.: "Cancer screening in women: body mass index and adherence to physician recommendations". Am. J. Prev. Med., 2007, 32, 525.
17. Wee C.C., Phillips R.S., McCarthy E.P.: "BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States". Obes. Res., 2005, 13, 1275.
18. International Diabetes Institute, WHO Regional Office for the Western Pacific. The Asia-Pacific perspective: Redefining obesity and its treatment. Health Communications Australia Pty Limit: Melbourne, 2000, 56.
19. Esposito K., Giugliano D.: "Obesity, the metabolic syndrome, and sexual dysfunction". Int. J. Impot. Res., 2005, 17, 391.
20. Kirchengast S., Hartmann B., Gruber D., Huber J.: "Decreased sexual interest and its relationship to body build in post-menopausal women". Maturitas, 1996, 23, 63.
21. Esposito K., Ciotola M., Marfella R., Di Tommaso D., Cobellis L., Giugliano D.: "The metabolic syndrome: a cause of sexual dysfunction in women". Int. J. Impot. Res., 2005, 17, 224.
22. Esposito K., Ciotola M., Giugliano F., Bisogni C., Schisano B., Autorino R., et al.: "Association of body weight with sexual function in women". Int. J. Impot. Res., 2007, 19, 353.
23. Kolotkin R.L., Binks M., Crosby R.D., Ostbye T., Gress R.E., Adams T.D.: "Obesity and sexual quality of life". Obesity, 2006, 14, 472.
24. Brody S.: "Slimness is associated with greater intercourse and lesser masturbation frequency". J. Sex. Marital. Ther., 2004, 30, 251.
25. Scott M., Nakagawa M., Moscicki A.B.: "Cell-mediated immune response to human papillomavirus infection". Clin. Diagn. Lab. Immunol., 2001, 8, 209.
26. McGlennen R.C.: "Human papillomavirus oncogenesis". Clin. Lab. Med., 2000, 20, 383.
27. zur Hausen H.: "Papillomaviruses and cancer: from basic studies to clinical application". Nat. Rev. Cancer, 2002, 2, 342.
28. Aggarwal B.B.: "Signalling pathways of the TNF superfamily: a double-edged sword". Nat. Rev. Immunol., 2003, 3, 745.
29. Kyo S., Inoue M., Hayasaka N., Inoue T., Yutsudo M., Tanizawa O., et al.: "Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines". Virology, 1994, 200, 130.
30. Soto U., Das B.C., Lengert M., Finzer P., zur Hausen H., Rosl F.: "Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex". Oncogene, 1999, 18, 3187.
31. Fantuzzi G.: "Adipose tissue, adipokines, and inflammation". J. Allergy Clin. Immunol., 2005, 115, 911.
32. Naz R.K., Butler A.: "Interleukins-6 and -8 levels in sera and cervical mucus of fertile, idiopathic infertile, and immunoinfertile women: implication in infertility". Am. J. Reprod. Immunol., 1996, 35, 534.
33. Naz R.K., Butler A., Witt B.R., Barad D., Menge A.C.: "Levels of interferon-gamma and tumor necrosis factor-alpha in sera and cervical mucus of fertile and infertile women: implication in infertility". J. Reprod. Immunol., 1995, 29, 105.
34. Castle P.E., Hildesheim A., Bowman F.P., Strickler H.D., Walker J.L., Pustilnik T., et al.: "Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels". J. Clin. Immunol., 2002, 22, 23.
35. Ahmed M.I., Salahy E.E., Fayed S.T., El-Hefnawy N.G., Khalifa A.: "Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha". Clin. Biochem., 2001, 34, 491.
36. Song S.H., Lee J.K., Seok O.S., Saw H.S.: "The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix". Gynecol. Oncol., 2007, 104, 732.
37. Villa L.L., Vieira K.B., Pei X.F., Schlegel R.: "Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18". Mol. Carcinog., 1992, 6, 5.
38. Jung W.W., Chun T., Sul D., Hwang K.W., Kang H.S., Lee D.J., et al.: "Strategies against human papillomavirus infection and cervical cancer". J. Microbiol., 2004, 42, 255.
39. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al.: "Prevalence of HPV infection among females in the United States". JAMA, 2007, 297, 813.
40. Shin H.R., Franceschi S., Vaccarella S., Roh J.W., Ju Y.H., Oh J.K., et al.: "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea". J. Infect. Dis., 2004, 190, 468.
41. Zhu J., Quyyumi A.A., Norman J.E., Csako G., Waclawiw M.A., Shearer G.M., et al.: "Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels". Am. J. Cardiol. 2000, 85, 140.
42. Nabipour I., Vahdat K., Jafari S.M., Pazoki R., Sanjdideh Z.: "The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study". Cardiovasc Diabetol., 2006, 5, 25.
43. Polterauer S., Grimm C., Tempfer C., Sliutz G., Speiser P.,Reinthaller A., et al.: "C-reactive protein is a prognostic parameter in patients with cervical cancer". Gynecol. Oncol., 2007, 107, 114.